Introduction {#s1}
============

The Lipophosphoglycan (LPG) is the most studied glycoconjugate expressed by *Leishmania*. It is a pathogen-associated molecular pattern (PAMP) covering the entire promastigote surface and flagellum and is implicated in a wide variety of events during the interaction of the parasite with vertebrate and invertebrate hosts. Inter and intraspecies polymorphisms in the LPGs and glycoinositolphospholipids (GIPLs) structures from several species have been reported as important for the virulence mechanisms especially during the innate immune compartment (Becker et al., [@B1]; de Veer et al., [@B9]; Spath et al., [@B37]; De Assis et al., [@B7]).

LPG comprises four distinct domains: a lipid anchor consisting of 1-*O*-alkyl-2-*lyso*-phosphatidylinositol, a central core represented by a heptassacaride Gal (α1,6)Gal(α1 (3)Gal~f~(β1,3)\[Glc(α1)-PO~4~\]Man(α1,3)Man(α1,4)-GlcN(α1), a conserved backbone of repeating Gal(β1,4)Man(α1)-PO~4~ units and a terminal oligosaccharide named cap (Turco and Descoteaux, [@B41]). Most of the polymorphisms in the structure of LPG are located in the repeat units and cap structures. Several functions have been attributed to LPG including: inhibition of phagosome maturation and acidification (Desjardins and Descoteaux, [@B10]; Vinet et al., [@B42]), inhibition of PKC (Holm et al., [@B18]), induction of PKR (de Carvalho Vivarini et al., [@B8]), induction of extracellular neutrophil networks (NETs) (Guimaraes-Costa et al., [@B17]; Gabriel et al., [@B13]), induction of heme-oxygenase I (Luz et al., [@B22]), LTB4 (Tavares et al., [@B38]), PPAR-γ (Lima et al., [@B21]) and modulation of NO/cytokines, MAPKs and NF-kB translocation, TLR2/TLR4 agonist (De Assis et al., [@B7]; Ibraim et al., [@B19]; Paranaíba et al., [@B27]; Nogueira et al., [@B25]). However, there are still uncertainties in how intraspecies structural and compositional polymorphisms of LPG affect parasite virulence.

Polymorphisms in the repeat units of LPGs have already been reported in several species/strains of *Leishmania* from Old and New World (De Assis et al., [@B7]). Studies on intraspecies LPG polymorphisms are scarce and used a limited number of strains. For example, in Old World strains of *L. donovani* (1S-1D and MONGI) (Mahoney et al., [@B24]), *L. major* (FV1 and LV39) (Dobson et al., [@B11]) and *L. tropica* (L747, L810, and L863) (Soares et al., [@B34]). On the other hand, most of the studies have characterized LPG polymorphisms in New World strains including: *L. infantum* (14 strains) (Coelho-Finamore et al., [@B5]), *L. enriettii* (L88 and Cobaia) (Paranaíba et al., [@B27]), and *L. amazonensis* (PH8 and Josefa) (Nogueira et al., [@B26]). Studies on the glycobiology of *L. braziliensis* started in 2005, where the structure of the LPG strain M2903 was characterized as important during the interaction with the sandfly vector (Soares et al., [@B35], [@B33]). In the procyclic form it has no side-chains branching-off the repeat units, whereas in the metacyclic stage it possesses 1-2 β-glucose side-chains (Soares et al., [@B35]). In mouse macrophages, *L. braziliensis* LPG was more pro-inflammatory than that of *L. infantum*. It was a stronger TLR2/TLR4 agonist inducing NO and cytokine production and NF-κB translocation (Ibraim et al., [@B19]). It is already known that intraspecies polymorphisms in the *L. infantum* LPG results in differential production of NO by murine macrophages (Coelho-Finamore et al., [@B5]). In this species, there are three types of LPG (I, II, and III) depending on the presence/absence of β-glucose side chains. Although *L. braziliensis* LPG is a very pro-inflammatory PAMP among different *Leishmania* species, nothing is known about intraspecies polymorphisms in this glycoconjugate.

In Americas, *L. braziliensis* causes either single cutaneous lesions (TL) at the site of the bite or metastasizes to the oronasopharyngeal mucosa (ML). Some lesions characterized as atypical (AL) of *L. braziliensis* have been previously reported by Guimarães et al. ([@B15]) and more recently by Quaresma et al. ([@B29]). Interestingly, some lesions are somewhat unusual, hindering correct clinical diagnosis. Those are so called atypical lesions (AL): they are lupoid, verrucous sometimes resembling to tumors that do not fit in the regular shape of the TL lesions. Previous findings showed a differential expression of cytokines/chemokines in AL patients compared to TL patients (Costa-Silva et al., [@B6]). AL lesions are more difficult to heal, and this was probably due to natural resistance to Sb-based chemotherapeutic schemes (Rugani et al., [@B30]). However, it is still unknown if LPGs from *L. braziliensis* may be responsible for the virulence degrees observed in several strains of this species.

Here, we intend to investigate if the intraspecies variability in LPGs from different clinical forms and hosts are associated to the immunopathological events in *L. braziliensis*.

Materials and Methods {#s2}
=====================

Ethics Statement
----------------

All animals were handled in strict accordance with animal practice as defined by Internal Ethics Committee in Animal Experimentation (CEUA) of Fundação Oswaldo Cruz (FIOCRUZ), Belo Horizonte, Minas Gerais (MG), Brazil (Protocol L-32/16). The procedures for strains isolation from humans were carried out in accordance with the recommendations of the National Committee for Research Ethics (CONEP \# 355/2008).

Cell Culture
------------

*Leishmania braziliensis* reference strains were used including: MHOM/BR/75/M2903 (TL), MHOM/BR/1996/M15991 (ML), IWELL/BR/1981/M8401 (vector). Other isolates included (RR051 and RR418) (TL) and RR410 (AL). Those strains were isolated from human patients in the Xakriabá indigenous community located in São João das Missões, Minas Gerais State, Brazil (Quaresma et al., [@B29]). Those strains were previously typed as reported (Rugani et al., [@B30]). Starter cultures of promastigotes were grown in supplemented Medium 199 as reported elsewhere (Soares et al., [@B36]).

Extraction and Purification of LPG
----------------------------------

LPG extraction was performed as described elsewhere with solvent E (H~2~O/ethanol/diethylether/pyridine/NH~4~OH; 15:15:5:1:0.017) after a sequential organic solvent extraction. For purification, the solvent E extract was dried under N~2~ evaporation, resuspended in 2 mL of 0.1N acetic acid/0.1 M NaCl, and applied onto a column with 2 mL of phenyl-Sepharose, equilibrated in the same buffer (Soares et al., [@B36], [@B34]).

Macrophages, Nitrite, and Cytokines
-----------------------------------

Thioglycollate-elicited peritoneal macrophages were extracted from C57BL/6 and C57BL/6 (TLR2 and TLR4 knockouts) as previously reported (Ibraim et al., [@B19]; Nogueira et al., [@B25]). Briefly, recovered cells (3 × 10^5^ cells/well) were washed with fresh RPMI and cultured in the same medium supplemented with 2 mM glutamine, 50 U/ml of penicillin and 50 μg/mL streptomycin, 10% Fetal Bovine Serum in 96-well culture plates (37°C, 5% CO~2~). Cells were primed with gamma interferon (IFN-γ) (3 IU/mL) for 18 h prior to incubation with LPGs (10 μg/mL) from all strains and controls for 48 h. Those included LPS (100 ng/mL, positive) and medium (negative). The nitrite concentration was measured by Griess reaction. For cytokine detection, supernatants were collected and IL-1β, IL-6, IL-12, and TNF-α were determined using BD CBA Mouse Cytokine assay kits according to the manufacturer\'s specifications (BD Biosciences, CA, USA). Flow cytometry measurements were performed on a FACS Calibur flow cytometry (BD Bioscience, Mountain View, CA, USA). Cell-Quest TM software package provided by the manufacturer was used for data acquisition and the FlowJo software 7.6.4 (Tree Star Inc., Ashland, OR, USA) was used for data analysis (Nogueira et al., [@B25]).

Western Blot
------------

Purified LPGs (10 μg) were resolved by SDS-PAGE electrophoresis and transferred to nitrocellulose membrane. Blots were probed with monoclonal antibody (mAb) CA7AE (1:1,000), that recognizes the unsubstituted Gal(β1,4)Man(α1)-PO~4~ repeat units (Tolson et al., [@B39]) and LT22 (1:1,000) that recognizes β-glucose/β-galactose side chains. After washing in PBS (3 × 5 min), the membrane was incubated for 1 h with antimouse IgG conjugated with peroxidase (1:10,000) and the reaction was visualized using luminol (Soares et al., [@B35]; Nogueira et al., [@B26]).

Biochemical Analysis
--------------------

Promastigotes were radiolabeled during stationary phase 1.0 × 10^8^-10^9^ cells/mL with 90 uCi/ml_of \[6-^3^H\]Gal at 26°C for 8 h as previously reported (Soares et al., [@B35]). \[3H-Gal\]-LPG was extracted and purified as described above. LPGs were depolymerized by mild acid hydrolysis (0.02 N HCl, 100°C, 5 min) in order to separate the repeating units and caps. Samples were subjected to the butanol: water partition (1:2) to remove core-PI motifs. Purified repeat units were recovered and subjected to enzymatic treatments with alkaline phosphatase prior to glycosidases (Mahoney et al., [@B24]). After enzymatic treatments, samples were desalted through a two-layered column of AG50W-X12(H+) over AG1-X8 (acetate). Phosphorylated oligosaccharides were treated with alkaline phosphatase in 15 mM Tris buffer, pH 9.0 (1 U, 16 h, 37°C). Neutral oligosaccharides were treated with sweet almond β-glucosidase in 200 mM ammonium acetate buffer, pH 5.0 (1 U, 16 h, 37°C). The repeat units treated with β-glucosidase were subject to thin layer chromatography technique (TLC). Samples were applied on silica plates and run in butanol pyridine water (6:4:3) solution for 20 h. Quantification of the radioactivity were performed using the Tri-Carb-1600 TR (Soares et al., [@B36]).

Data Analyses
-------------

Statistical analyses and graphics construction were performed using one-way ANOVA test with Software GraphPad Prism 6.0 (GraphPadSoftware Inc., San Diego, CA, EUA). The analyses were done after normality test of Kolmogorov-Smirnov. *P* \< 0.05 was considered significant.

Results {#s3}
=======

Macrophage Activation
---------------------

Murine macrophages were exposed to LPGs from different strains to evaluate the impact on the innate immune response. In general, the various LPGs induced NO, IL-6, IL-12, and TNF-α production preferentially via TLR4 ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}). However, this production varied among *L. braziliensis* strains. For example, LPG from M15991strain (ML) did not induce considerable levels of NO and cytokines. On the other hand, the LPG from the vector strain (M8401) was very proinflammatory inducing NO and cytokine levels similar to LPS ([Figures 1](#F1){ref-type="fig"}, [2A--C](#F2){ref-type="fig"}). In general, LPGs from AL/TL strains RR410/RR418 induced higher levels of NO and cytokines than LPG from TL strains M2903, RR051, and M15991 (ML) in the TLR2 KO but not WT macrophages ([Figures 1](#F1){ref-type="fig"}, [2A--C](#F2){ref-type="fig"}). No detectable IL-1β production was induced by the different LPGs used in this study (data not shown).

![Nitrite production by IFN-γ primed macrophages stimulated with *L. braziliensis* LPGs from patients with different clinical manifestations and the sandfly vector. Cells were pre-incubated with IFN-γ (3 IU/mL) for the 18 h prior to LPG exposure (10 μg/mL) and LPS (100 ng/mL, positive control) for 48 h. Fresh medium alone was used as negative control. Nitrite concentration was measured by Griess reaction. C, negative control; M2903, RR051, and RR418, *L. braziliensis* LPG isolated from typical lesions; RR410, LPG of *L. braziliensis* from atypical lesion; M15991, LPG isolated from mucocutaneous lesion; M8401, *L. braziliensis* LPG isolated from sandfly. \**P* \< 0.05 was considered significant.](fcimb-09-00240-g0001){#F1}

![Cytokine production by IFN-γ primed macrophages stimulated with *L. brazilienis* LPGs from patients with different clinical manifestations and the sandfly vector. Cells were pre-incubated with IFN-γ (3 IU/mL) for the 18 h prior to LPG exposure (10 μg/mL) and LPS (100 ng/mL, positive control) for 48 h. Fresh medium alone was used as negative control. Cytokine concentrations of IL-6 **(A)**, IL-12 **(B)**, and TNF-α **(C)** were determined by flow cytometry. C, negative control; M2903, RR051, and RR418, *L. braziliensis* LPG isolated from typical lesions; RR410, LPG of *L. braziliensis* from atypical lesion; M15991, LPG isolated from mucocutaneous lesion; M8401, *L. braziliensis* LPG isolated from sandfly. \**P* \< 0.05 was considered significant.](fcimb-09-00240-g0002){#F2}

Biochemical Analysis
--------------------

To detect if variations in macrophage responses could be functionally attributed to intraspecies polymorphisms among *L. braziliensis* LPGs, we performed a biochemical analysis of these molecules. First, a preliminary analysis using western blot with specific antibodies was conducted. In general, both antibodies recognized all purified LPGs confirming the success of the purification process. However, based on the profiles, the smears suggest the existence of polymorphisms ([Figures 3A,B](#F3){ref-type="fig"}). For CA7AE, all LPGs were recognized by this antibody confirming the existence of Gal(β1,4)Man(α1)-PO~4~ motifs common to all LPGs (Soares et al., [@B35]). Different from CA7AE, LT22 exhibited a more evident polymorphisms among strains. For example, RR051 followed by M2903 strain were strongly recognized by this antibody. Those data suggest the existence of sugars branching-off the repeat units in some of the strains. Interestingly, M15991 strain, who was weakly recognized by CA7AE, was also detected very poorly by LT22. Although the western blot analyses suggest the existence of polymorphisms in the repeat units, a deeper biochemical analysis using TLC was required. To this end, purified LPGs were depolymerized and subjected to TLC analysis. The repeat units from the M15991 (ML) and M8401 (vector) strains were similar and devoid of side-chains exhibiting only a disaccharide peak ([Figures 4A,B](#F4){ref-type="fig"}). As expected, the repeat units of M2903 LPG (control) exhibited a di-, tri- and tetrasaccharide as previously reported (Soares et al., [@B35]) ([Figure 5A](#F5){ref-type="fig"}). This profile was also observed for AL isolate RR410 ([Figure 5B](#F5){ref-type="fig"}). The repeat units of RR051 isolate exhibited a tri- and a disaccharide ([Figure 5C](#F5){ref-type="fig"}, closed circles). In order to confirm if the side-chains were composed by β-glucose residues that could justify its reactivity to LT22 ([Figure 3B](#F3){ref-type="fig"}), treatment with β-glucosidase was performed. After enzymatic treatment, the trisaccharide disappeared and the disaccharide peak increased confirming the presence of β-glucoses as side-chains ([Figure 5C](#F5){ref-type="fig"}, open circles). A similar result was observed for strain RR418 (data not shown). Altogether, those data indicate the presence of side-chains in the LPG repeat units of those strains.

![Western blot of purified lipophosphoglycan (LPG). Purified LPG (10 μg per lane) from promastigotes of *L. braziliensis* strains (M2903, RR051, RR418, RR410, M15991, and M8401) were incubated with the antibody CA7AE (1:1,000) **(A)** and LT22 (1:1,000) **(B)**. LPG purified from *L. braziliensis* M2903 strain was used as positive control. TL, Typical lesions; AL, Atypical lesions; ML, Mucocutaneous strain; VEC, Vector strain.](fcimb-09-00240-g0003){#F3}

![Thin layer chromatography (TLC) of dephosphorylated \[^3^H\]Gal-repeat units obtained from different *L. braziliensis* LPGs. **(A)** M15991 repeat units and **(B)** M8401 repeat units. Gal, galactose; Man, mannose.](fcimb-09-00240-g0004){#F4}

![Thin layer chromatography (TLC) of dephosphorylated \[^3^H\]Gal-repeat units obtained from different *L. braziliensis* LPGs. **(A)** M2903 repeat units, **(B)** RR410, and **(C)** RR051 treated (open circles) or not (closed circles) with β-glucosidase. Glc, glucose; Gal, galactose; Man, mannose.](fcimb-09-00240-g0005){#F5}

Discussion {#s4}
==========

Several factors may be related to the different levels of virulence among strains of a given *Leishmania* species. In the case of *L. braziliensis*, this species causes several clinical manifestations ranging from single lesions to atypical and/or severe mucocutaneous forms (Guimarães et al., [@B16]; Quaresma et al., [@B29]). Here, we investigated the role of LPG during the activation of macrophages from the innate immune compartment. An early and successful activation of this compartment is important for the fate of the acquired immune responses especially in parasitic diseases caused by Protozoa (Gazzinelli et al., [@B14]). Early studies with Old World *Leishmania* species already reported the role of LPG for the induction of cytokines, NO and MAPKs (Brittingham and Mosser, [@B3]; Feng et al., [@B12]). This triggered a lot of interest in establishing the TLRs involved in the innate immune responses in the hosts \[revised by (Tuon et al., [@B40])\]. In this context, *L. major* LPG was the first TLR2 agonist reported for human natural-killer (NK) cells and murine macrophages. This activation triggers the production of TNF-γ and IFN-γ via MyD88 and is dependent on the integrity of the lipid anchor (Becker et al., [@B1]; de Veer et al., [@B9]). Consistent with those results, the integrity of the lipid anchor of *L. infantum* LPG was also required for the activation of PPAR-γ (Lima et al., [@B21]). In *L. braziliensis* (M2903 strain), it was previously reported that its LPG activates NO and cytokines production via TLR4/TLR2. A distinguishing feature of this LPG is the very pro-inflammatory profile compared to that of *L. infantum* (Ibraim et al., [@B19]). Here, this pro-inflammatory effect remained, but other strains (RR418, RR410, and M8401) exhibited a higher ability to induce NO and cytokines than M2903 especially in the TLR2 knockout. However, those differences were not observed in the WT. Those data confirmed that LPGs from different strains/isolates have variable immuno-modulatory activities toward murine macrophages. Based on our data, this activation was mediated by TLR4, similar to other dermotropic species such as *L. amazonensis* and *L. enriettii* (Paranaíba et al., [@B27]; Nogueira et al., [@B25]).

To investigate whether LPG polymorphisms correlated with clinical forms of leishmaniasis, macrophages were stimulated with glycoconjugates purified from *L. braziliensis* from different patients. The LPG from AL strain (RR410) induced a high NO and cytokine production than most of TL and ML strains. Interestingly, the LPG isolated from a vector strain (M8401), exhibited the highest pro-inflammatory activity, comparable to that of LPS. Our results confirm those in the literature that murine macrophages are able to produce NO in response to LPG, and that this production is variable among species/strains (Coelho-Finamore et al., [@B5]; Ibraim et al., [@B19]; Paranaíba et al., [@B27]; Nogueira et al., [@B25]). Cytokines are very important during immunopathology of Leishmaniasis. For example, IL-1β and IL-6 are important proinflammatory cytokines acting on endothelial cells by increasing the number of adhesion molecules and migration of leukocytes to the site of inflammation. This favor tissue damage by increasing inflammation by attracting and activating neutrophils (Castellucci et al., [@B4]; Boaventura et al., [@B2]; Sallusto et al., [@B32]). In our study, an important induction of IL-6 was noticed in most of the strains, suggesting the role of *L. braziliensis* LPG in this process. On the other hand, the reference strain from the mucocutaneous lesion (M15991) induced a very low production of NO and cytokines, a response similar to that of *L. infantum* LPG (Ibraim et al., [@B19]). Many aspects of the immunopathology of ML strains are still unknown, especially those related to metastasis from the bite site to the oropharyngeal mucosa. This low proinflammatory potential of the LPG from the ML strain strongly suggests that other molecules such as GP63, GIPLs, and PPGs could be important during macrophage response (De Assis et al., [@B7]). Consistent with this, M15991 strain does not possesses LRV1 (*Leishmaniavirus*) (Macedo et al., [@B23]), reinforcing that other strain-specific factors and perhaps from the host could be primarily involved in the immunopathology of ML. Interestingly, there was increased production of NO, IL-6, and TNF-α by the isolated strain from an atypical lesion (AL). AL lesions exhibited an aspect macroscopically different from the common TL lesion (ulcerated with elevated borders) (Costa-Silva et al., [@B6]; Quaresma et al., [@B29]). In general, the LPG of the RR410 strain was more pro-inflammatory than those of the TL/ML lesions mainly for the TLR2 knockout (IL-6 and IL-12). This reinforces that other factors such as genetics could be responsible for these unusual forms. Recently, it was reported that AL causing strains have a SNP in the 1,300 bp hsp70 gene fragment that clustered them in a group separated from TL/ML strains (Quaresma et al., [@B29]). Altogether our data show that the mechanisms underlying macrophage modulation by LPG clearly vary among strains/isolates of *L. braziliensis* and are not easily correlated with pathology.

To investigate whether those differences could be due to polymorphisms in the LPG, preliminary analyzes using western-blot were performed. All LPGs were recognized by the CA7AE antibody. The LPG from M15991 strain was weakly recognized by this antibody. However, most LPGs were recognized by this mAb suggesting that they possess most of unsubstituted repeat units. This feature is commonly observed in *L. infantum* type I LPG (10 strains), *L. enriettii* (two strains), *Leishmania shawi*, and *L. donovani* (Sudan strain) (Sacks et al., [@B31]; Coelho-Finamore et al., [@B5]; Paranaíba et al., [@B27]; Passero et al., [@B28]). On the other hand, the presence of side-chains suggestive of glucoses (LT22 positive) was strongly detected in the LPG from RR051strain followed by M2903. This is consistent with the literature that the LPG of M2903 (positive control) from stationary phase possess 1-2 β-glucose side-chains (Soares et al., [@B35]). Those sugars are also observed in the LPG from *L. infantum* (strains PP75 and BH46), *L. amazonensis* (PH8 strain), and *L. donovani* (Mongi strain) (Mahoney et al., [@B24]; Soares et al., [@B36]; Coelho-Finamore et al., [@B5]; Nogueira et al., [@B26]). The other strains (RR418, RR410. M15991, and M8401) exhibited lower recognition by this mAb suggesting that some of the repeat units could be substituted with side-chains and this should be confirmed by TLC analysis. Those data suggest intraspecies polymorphisms in the purified repeat units from *L. braziliensis* LPGs.

To detect polymorphisms in the repeating units, we chose five *L. braziliensis* LPGs displaying different patterns, as assessed by western blots. LPGs were radioactively labeled to increase sensitivity, since *L. braziliensis* express lesser amounts of this glycoconjugate than other *Leishmania* species (Soares et al., [@B35]). The results indicated evident polymorphisms in the repeat units. The strains M15991 and M8401 possess LPGs without side chain confirming their basic structure of Gal(β1,4)Man(α1)-PO~4~ (Sacks et al., [@B31]). Although LPG expressed by strain M15991 was weakly recognized by CA7AE, it exhibited a clear disaccharide peak confirming the existence of unbranched repeating units. As expected, TLC analysis of LPG from strain M2903 (control) confirmed the existence of di-, tri- and tetrasaccharides as previously described (Soares et al., [@B35]). Confirming the western-blot data, in addition to a disaccharide, the LPG of RR051 also exhibited a tetrasaccharide peak. After enzymatic treatment with β-glucosidase this peak disappeared followed by an increase in the disaccharide peak. This confirmed the existence of β-glucoses as side-chains. Similar results were also observed for RR418 (data not shown), *L. infantum* and *L. mexicana* (Ilg et al., [@B20]; Soares et al., [@B36]). Those data confirmed that β-glucoses are the most common side chains found in the LPGs from New World species of *Leishmania*.

Those polymorphisms were functionally compared during macrophage studies. Depending on the cytokine/NO a correlation could be established. For example, the production of NO, TNF-α and IL-6 by WT murine macrophages was higher in response to glucosylated LPGs (M2903, RR051, and RR410) than that of unbranched LPG from M15991. However, for M8401 this correlation could not be established. It has an unbranched LPG but alike M15991 it exhibited a high pro-inflammatory activity. It is not likely that this feature is due to the presence of side-chains since it does not have it. Conversely, we could postulate that this could be due to a longer LPG size. This was already reported in another dermotropic species *L. enriettii*. Two strains of this species were compared and the LPG of L88 strain (longer size) was more pro-inflammatory than that of the Cobaia strain (short size) (Paranaíba et al., [@B27]). Those data suggested that LPG qualitative variations either in sugars branching-off the repeating units or size could differentially modulate macrophage responses. However, this is dependent on species/strains. For example, in *L. infantum* the presence of glycosylated LPGs (strains PP75 and BH46) triggered a higher NO production compared to unsubstituted (type I) LPGs (Coelho-Finamore et al., [@B5]). On the other hand, in *L. amazonensis*, polymorphisms in the sugar side-chains were not important for macrophage activation and this could be attributed to the lipid anchor (Nogueira et al., [@B26]).

In conclusion, our study showed that strains/isolates of *L. braziliensis* differentially activated murine macrophages via TLR4. We found considerable structural and compositional polymorphisms in the side-chains of these LPGs that could affect interaction with this TLR, although a clear correlation between structure and function could not be established. *Leishmania*-macrophage interaction process is very complex involving parasite and immune cells molecules. Our data reinforce the idea that not only LPG but other molecules play an important role during the interface parasite-host and perhaps affect the immunopathology. Based on our work, differences in virulence/pathogenicity are strongly dependent on species/strains. This is surely the case of the *L. braziliensis*, a species causing a spectrum of dermotropic diseases.
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